98%
921
2 minutes
20
Introduction: Polycystic ovary syndrome (PCOS), a common metabolic-endocrine disorder, is linked to low-quality carbohydrate intake, though evidence remains controversial. This research aimed to evaluate carbohydrate quantity/quality impacts on PCOS by combining global trends from the Global Burden of Disease (GBD) 2021 database with pooled study from individual-level data.
Methods: We analyzed GBD 2021 data to assess annual trends in PCOS incidence and low-grain/high-sugar-sweetened beverage consumption. Six databases were searched until February 2025 to identify population-based studies for meta-analysis. Results were expressed as mean differences (MD) with 95 % CIs, and heterogeneity was evaluated using χ tests and I statistics.
Results: GBD 2021 data revealed rising PCOS incidence alongside increased low whole-grain intake and high sugar-sweetened beverage consumption. This meta-analysis of 25 studies (n = 20,738) found no significant difference in total carbohydrate intake between PCOS and non-PCOS women. However, women with PCOS had significantly higher refined grain intake (SMD (95 % CI) = 0.66 [0.09, 1.24]) and lower whole grains (SMD (95 % CI) = -0.64 [-1.34, 0.07]) and fiber intake (MD (95 % CI) = -1.83 [-3.80, 0.13]). Subgroup analyses demonstrated significantly reduced fiber intake in overweight (MD = -2.92 [95 % CI: 4.64 to -1.21]) and non-diabetic women with PCOS (MD = -1.40 [95 % CI: 2.42 to -0.38]).
Conclusion: Compared with carbohydrate quantity, lower-quality carbohydrate intake-characterized by higher refined grain consumption and lower intake of fiber and whole grains-appears to be more closely associated with PCOS. Different metabolic phenotypes in PCOS may require personalized dietary strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.dsx.2025.103277 | DOI Listing |
PLoS One
September 2025
Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Background: Head and neck cancer (HNC) is a significant global health concern with rising incidence and mortality in certain regions. This study aimed to evaluate the global burden and temporal trends of HNC from 1990 to 2021 and to project its future burden through 2030.
Methods: Data were obtained from the Global Burden of Disease (GBD) 2021 study.
Neurol Sci
September 2025
School of Public Health, Shaanxi University of Chinese Medicine, Shaanxi, 712046, Xianyang, P. R. China.
Background: Stroke persists as the second leading global cause of mortality and disability. We analyzed G20 nations using Global Burden of Disease (GBD) 2021 data (1990-2021) to provide a new perspective.
Methods: We obtained age-standardized rates (ASR) of stroke mortality, incidence, prevalence, and YLLs (years of life lost) across G20 nations.
Liver Int
October 2025
The Global NASH Council, Washington, DC, USA.
Background: The Middle East and North Africa (MENA) region is undergoing demographic shifts potentially increasing metabolic dysfunction-associated steatotic liver disease (MASLD) and its complications. We assessed MASLD prevalence and liver disease burden from 2010 to 2021.
Methods: Data from Global Burden of Disease (GBD), United Nations Population Division and NCD Risk Factor Collaboration covering 21 MENA countries were used for annual percent change (APC) trends per Joinpoint regression.
Front Oncol
August 2025
Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Background: Ovarian cancer (OC) and uterine cancer (UC) are significant public health concerns among women of reproductive age. High body mass index (BMI) contributes to the increasing burden of these cancers globally, but comprehensive epidemiological assessments remain limited.
Methods: Data were obtained from the Global Burden of Disease (GBD) Study 2021 (1990-2021).
Front Oncol
August 2025
Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital, Hainan Medical University, Haikou, China.
Background: Laryngeal cancer (LC), the second most common head and neck malignancy, with significant global geographical disparities in incidence and mortality, was analyzed using 2021 Global Burden of Disease (GBD) data to assess Socio-Demographic Index (SDI) correlations and project disease burden through 2050, aiming to reduce its global impact.
Methods: Using data from the GBD 2021, we investigated the incidence, prevalence, deaths, and Disability-Adjusted Life Years (DALYs) of LC, as well as trends, age-sex-time patterns, driving factors, and projections up to 2050.
Results: In 2021, LC increased with age and decreased after the age of 70.